| Dr Laura K Hassen, MD | |
|
55 Maui Lani Pkwy, Wailuku, HI 96793-2416 | |
| (808) 243-6050 | |
| Not Available |
| Full Name | Dr Laura K Hassen |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 55 Maui Lani Pkwy, Wailuku, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356455042 | NPI | - | NPPES |
| 010191599 | Medicaid | VA | |
| 409034 | Other | SOUTHERN HEALTH | |
| 182314 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101-237956 (Virginia) | Secondary |
| 208000000X | Pediatrics | MD-17115 (Hawaii) | Primary |
| Entity Name | Hawaii Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945969 PECOS PAC ID: 7618880667 Enrollment ID: O20031106000625 |
News Archive
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
For those who suffer from fainting spells, the mysterious episodes can be quite scary. Far too often, fainting is chalked up to stress or other mental health issues. However, medical experts at Rush University Medical Center say that reoccurring fainting spells, also known as syncope, could be an important symptom that can point to a more serious, underlying cardiovascular condition.
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters <232> Elemental Impurities-Limits and <233> Elemental Impurities-Procedures. The new standards provide procedures for the detection of selected impurities in drug products based on modern analytical methods, as well as acceptable limits for their presence based on toxicity data and exposure levels.
To coincide with World Cancer Day 2011, on 4 February, the Africa Oxford Cancer Foundation (AfrOx) and the European Society for Medical Oncology (ESMO) are working together to raise international awareness of the growing problem of cancer in Africa.
The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura K Hassen, MD 55 Maui Lani Pkwy, Wailuku, HI 96793-2416 Ph: (808) 243-6050 | Dr Laura K Hassen, MD 55 Maui Lani Pkwy, Wailuku, HI 96793-2416 Ph: (808) 243-6050 |
News Archive
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
For those who suffer from fainting spells, the mysterious episodes can be quite scary. Far too often, fainting is chalked up to stress or other mental health issues. However, medical experts at Rush University Medical Center say that reoccurring fainting spells, also known as syncope, could be an important symptom that can point to a more serious, underlying cardiovascular condition.
As part of its ongoing efforts to help ensure the quality of medicines, the U.S. Pharmacopeial Convention (USP) has announced two new standards related to elemental impurities: General Chapters <232> Elemental Impurities-Limits and <233> Elemental Impurities-Procedures. The new standards provide procedures for the detection of selected impurities in drug products based on modern analytical methods, as well as acceptable limits for their presence based on toxicity data and exposure levels.
To coincide with World Cancer Day 2011, on 4 February, the Africa Oxford Cancer Foundation (AfrOx) and the European Society for Medical Oncology (ESMO) are working together to raise international awareness of the growing problem of cancer in Africa.
The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.
› Verified 8 days ago
Maria A. Matijasevic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Maui Lani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 | |
Dr. Douglas J Gamet, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6125 Fax: 808-243-6134 | |
David M. Bacchus, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Maui Lani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 | |
Dr. Garry Cameron, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1881 Nani St, Wailuku, HI 96793 Phone: 808-871-7772 Fax: 808-872-4031 | |
Dr. David M. Ulin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 | |
Dr. Christina Efthimiadis Seeley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 221 Mahalani St, Wailuku, HI 96793 Phone: 808-793-8009 | |
Dr. Roxanne Bhattacharya, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-242-6464 Fax: 808-243-2385 |